@franksdavid.bsky.social - Frank S. David

21 Oct 2025 16:42 +0000

Hey, folks -- please show some love/encouragement to a recent Bio MS grad (on the job market!) who's blogging about biomedical research in the Mideast and North Africa: https://www.linkedin.com/newsletters/7384732610029174784/

18 Sep 2025 20:31 +0000

Hi, folks! I just posted another "links list" of biopharma-relevant stuff that caught my attention (incl. "AI and Alzheimer's cures" -- color me skeptical). https://mailchi.mp/pharmagellan/btd-17469990

14 Aug 2025 11:21 +0000

New essay on measuring biopharma innovation in The Incidental Economist -- led by @sukhunkang.bsky.social; I pitched in: https://theincidentaleconomist.com/wordpress/measuring-biopharmaceutical-innovation-in-the-modern-era/

08 Aug 2025 00:09 +0000

My latest "link list": https://mailchi.mp/pharmagellan/btd-17469341

29 Jul 2025 11:35 +0000

My unsexy but easy suggestion for Marty Makary M.D., M.P.H. on boosting "radical transparency" at the FDA: https://www.statnews.com/2025/07/29/fda-transparency-marty-makary-approved-drug-pdfs-efficiency/

13 Jul 2025 22:31 +0000

New (from me): blogging advice for folks who want to get into biotech strategy or finance, incl. resources, examples, and tips to get started: https://www.linkedin.com/pulse/you-should-start-biotech-blog-frank-s-david-tj7ve/

02 Jul 2025 10:17 +0000

Hi, folks -- here's my inaugural "links list" of recent items that caught my eye in biotech R&D and other areas. Please let me know what you think! eepurl.com/jih0E2 http://eepurl.com/jih0E2

20 Jun 2025 16:22 +0000

Generics FTW. Also, anyone even mildly interested in drug pricing should read Peter Kolchinsky’s “Great American Drug Deal”. [contains quote post or other embedded content]

19 Jun 2025 15:47 +0000

Good resource for biotech entrepreneurs (HT @wilbanks.bsky.social) [contains quote post or other embedded content]

17 Jun 2025 11:32 +0000

Apparently hope *is* a strategy after all. https://endpoints.news/roche-moves-ahead-with-phase-3-parkinsons-study-despite-mixed-trial-results/ by @leileiwu.bsky.social of Endpoints

13 Jun 2025 16:34 +0000

Good piece —> [contains quote post or other embedded content]

13 Jun 2025 10:54 +0000

Great thread — bookmarking for my drug dev class. HT @thewonkologist.bsky.social [contains quote post or other embedded content]

12 Jun 2025 10:04 +0000

Love this — I’ve sent it to many Tufts Bio students. (So far only 1 has started a blog, but I’m not giving up.) [contains quote post or other embedded content]

11 Jun 2025 20:20 +0000

Me: “FIVE hours?” Also me: [contains quote post or other embedded content]

10 Jun 2025 21:00 +0000

I don’t follow the generics market closely, let alone international Gx — so I found this piece by @dereklowe.bsky.social particularly bananas! Go read it. https://www.science.org/content/blog-post/novo-nordisk-s-canadian-mistake

10 Jun 2025 13:05 +0000

Good reading recs here from Jacob Trefethen of Open Phil: https://blog.jacobtrefethen.com/science-writing/

06 Jun 2025 16:22 +0000

Valid point

05 Jun 2025 15:50 +0000

Good template for a clear paper abstract — HT @johnholbein1.bsky.social (who credits @fgilardi.bsky.social)

05 Jun 2025 15:43 +0000

New paper on pharma revenue drivers by IDEA Pharma — here’s the TL;DR (w/apologies to Michael Pollan; IYKYK): “Spend on R&D. Not too much. Mostly Phase 3 trials.” https://www.ideapharma.com/insights/revenue-determinants-in-pharma/

05 Jun 2025 12:34 +0000

New “Healthspan” whitepaper by the folks at Whoop. I’m skeptical of these sorts of things but I haven’t read it yet and this isn’t my expertise. Curious to hear thoughts from @dshaywitz.bsky.social and others who follow this area. https://www.whoop.com/us/en/thelocker/Healthspan-Data-Meets-Longevity/

05 Jun 2025 10:12 +0000

Most cogent “bear case” I’ve read on where we are / where we’re going on AI. By Dwarkesh Patel: https://www.dwarkesh.com/p/timelines-june-2025

04 Jun 2025 17:14 +0000

Big “college student seeing final course grade” energy(Rep. Jason Smith (R-MO) via NYT).